Bullfrog AI (NASDAQ:BFRG) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Bullfrog AI (NASDAQ:BFRG) posted its quarterly earnings results on Friday. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.09) by ($0.02), FiscalAI reports. The firm had revenue of $0.06 million during the quarter, compared to analyst estimates of $0.21 million.

Bullfrog AI Stock Performance

Shares of NASDAQ BFRG traded down $0.01 during mid-day trading on Friday, reaching $0.54. 92,404 shares of the company’s stock were exchanged, compared to its average volume of 5,027,268. The company’s 50-day moving average is $0.55 and its 200-day moving average is $0.64. The firm has a market capitalization of $10.04 million, a price-to-earnings ratio of -1.18 and a beta of -2.60. Bullfrog AI has a 52-week low of $0.43 and a 52-week high of $1.96.

Insider Activity

In related news, CFO Joshua Blacher bought 50,000 shares of the stock in a transaction on Tuesday, September 22nd. The stock was bought at an average price of $0.53 per share, with a total value of $26,500.00. Following the completion of the purchase, the chief financial officer directly owned 65,000 shares in the company, valued at $34,450. This represents a 333.33% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Vininder Singh purchased 75,000 shares of the company’s stock in a transaction on Tuesday, September 22nd. The shares were bought at an average price of $0.60 per share, with a total value of $45,000.00. Following the completion of the transaction, the chief executive officer owned 2,442,446 shares of the company’s stock, valued at approximately $1,465,467.60. The trade was a 3.17% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 14.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Bullfrog AI from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, October 2nd. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Reduce”.

Bullfrog AI Company Profile

BullFrog AI Holdings, Inc. is a biotechnology-focused artificial intelligence company that develops machine-learning tools for the healthcare and life sciences industries. The company’s work is centered on using artificial intelligence to analyze complex biomedical data and support more efficient approaches to drug development and precision medicine. Its primary technology platform, bfLEAP, is designed to process and interpret large datasets, including genomic and clinical information. BullFrog AI offers data analysis and related services intended to help pharmaceutical companies, biotechnology firms, researchers and other healthcare organizations identify patterns, potential biomarkers, patient subgroups and other insights that may inform therapeutic development.